SPONSOR
Fei Gao
Total Trials
2
Recruiting
2
Phases
Phase 2
Fei Gao is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma, Hepatocellular Carcinoma with PVTT.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fei Gao
How many clinical trials has Fei Gao sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Fei Gao, of which 2 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma, Hepatocellular Carcinoma with PVTT. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fei Gao research focus on?
Fei Gao clinical trials span Hepatocellular Carcinoma, Hepatocellular Carcinoma with PVTT. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fei Gao clinical trial?
To participate in a Fei Gao trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fei Gao trials with current recruitment status updated daily.
Clinical Trials by Fei Gao
NCT05882370 Phase 2
Recruiting
TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
Hepatocellular Carcinoma
NCT06646198 Phase 2
Recruiting
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Hepatocellular Carcinoma with PVTT
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology